Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables changed +12.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed +10.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating income changed +102.5% from the comparable as-filed period.
Cash & equivalents changed -46.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed +24.7% from the comparable as-filed period.
Operating cash flow changed -154.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -80.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed -188 basis points from the comparable as-filed period.
Trade receivables changed -11.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -142.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed -143.9% from the comparable as-filed period.
Operating margin changed -827 basis points from the comparable as-filed period.
Gross margin changed -258 basis points from the comparable as-filed period.
Inventory changed +9.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Cash & equivalents changed -28.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -12.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.